These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 32516469)

  • 1. National postoperative and oncologic outcomes after pelvic exenteration for T4b rectal cancer.
    Konstantinidis IT; Lee B; Trisal V; Paz I; Melstrom K; Sentovich S; Lai L; Raoof M
    J Surg Oncol; 2020 Sep; 122(4):739-744. PubMed ID: 32516469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Efficacy analysis of neoadjuvant chemoradiotherapy combined with total pelvic exenteration in the treatment of primary T4b rectal cancer].
    Wu T; Wen L; Zhang J; Wu Y; Jiang Y; Chen G; Wang X; Huang S; Wan Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jan; 22(1):59-65. PubMed ID: 30703795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A qualitative study of the development of a multidisciplinary case conference review methodology to reduce involved margins in pelvic exenteration surgery for recurrent rectal cancer.
    van Ramshorst GH; O'Shannassy S; Brown WE; Kench JG; Solomon MJ
    Colorectal Dis; 2018 Nov; 20(11):1004-1013. PubMed ID: 29920909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Urinary complications of pelvic exenterations for rectal cancer with urinary invasion].
    Gas J; Beauval JB; Chalret du Rieu M; Bou Nasr E; Philis A; Kirzin S; Thoulouzan M; Soulié M; Ghouti L
    Prog Urol; 2015 May; 25(6):348-54. PubMed ID: 25804429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Systematic Review to Assess Resection Margin Status After Abdominoperineal Excision and Pelvic Exenteration for Rectal Cancer.
    Simillis C; Baird DL; Kontovounisios C; Pawa N; Brown G; Rasheed S; Tekkis PP
    Ann Surg; 2017 Feb; 265(2):291-299. PubMed ID: 27537531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surgical and Survival Outcomes Following Pelvic Exenteration for Locally Advanced Primary Rectal Cancer: Results From an International Collaboration.
    PelvEx Collaborative
    Ann Surg; 2019 Feb; 269(2):315-321. PubMed ID: 28938268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Indications for primary and secondary exenterations in patients with cervical cancer.
    Marnitz S; Köhler C; Müller M; Behrens K; Hasenbein K; Schneider A
    Gynecol Oncol; 2006 Dec; 103(3):1023-30. PubMed ID: 16890276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does radiotherapy of the primary rectal cancer affect prognosis after pelvic exenteration for recurrent rectal cancer?
    Rombouts AJ; Koh CE; Young JM; Masya L; Roberts R; De-Loyde K; de Wilt JH; Solomon MJ
    Dis Colon Rectum; 2015 Jan; 58(1):65-73. PubMed ID: 25489696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of pelvic exenteration in the management of locally advanced primary and recurrent rectal cancer.
    Xin KY; Ng DW; Tan GH; Teo MC
    J Gastrointest Cancer; 2014 Sep; 45(3):291-7. PubMed ID: 24563189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pelvic exenterations for primary rectal cancer: Analysis from a 10-year national prospective database.
    Pellino G; Biondo S; Codina Cazador A; Enríquez-Navascues JM; Espín-Basany E; Roig-Vila JV; García-Granero E;
    World J Gastroenterol; 2018 Dec; 24(45):5144-5153. PubMed ID: 30568391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simultaneous pelvic exenteration and liver resection for primary rectal cancer with synchronous liver metastases: results from the PelvEx Collaborative.
    PelvEx Collaborative
    Colorectal Dis; 2020 Oct; 22(10):1258-1262. PubMed ID: 32294308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Total pelvic exenteration and rectal cancer. Apropos of 20 cases].
    Lasser P; Doidy L; Elias D; Lusinchi A; Sabourin JC; Bonvalot S; Ducreux M
    Chirurgie; 1999 Jun; 124(3):252-7. PubMed ID: 10429298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Minimally invasive versus open pelvic exenterations for rectal cancer: a comparative analysis of perioperative and 3-year oncological outcomes.
    Kazi M; Kumar NAN; Rohila J; Sukumar V; Engineer R; Ankathi S; Desouza A; Saklani A
    BJS Open; 2021 Sep; 5(5):. PubMed ID: 34518872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors affecting outcomes following pelvic exenteration for locally recurrent rectal cancer.
    PelvEx Collaborative
    Br J Surg; 2018 May; 105(6):650-657. PubMed ID: 29529336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association Between Incomplete Neoadjuvant Radiotherapy and Survival for Patients With Locally Advanced Rectal Cancer.
    Freischlag K; Sun Z; Adam MA; Kim J; Palta M; Czito BG; Migaly J; Mantyh CR
    JAMA Surg; 2017 Jun; 152(6):558-564. PubMed ID: 28273303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of tumor size on outcomes following pelvic exenteration.
    Smith B; Jones EL; Kitano M; Gleisner AL; Lyell NJ; Cheng G; McCarter MD; Abdel-Misih S; Backes FJ
    Gynecol Oncol; 2017 Nov; 147(2):345-350. PubMed ID: 28822555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extended sacropelvic resection for locally recurrent rectal cancer: can it be done safely and with good oncologic outcomes?
    Colibaseanu DT; Dozois EJ; Mathis KL; Rose PS; Ugarte ML; Abdelsattar ZM; Williams MD; Larson DW
    Dis Colon Rectum; 2014 Jan; 57(1):47-55. PubMed ID: 24316945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Robot-assisted total pelvic exenteration for rectal cancer after neoadjuvant chemoradiotherapy: a case report.
    Kihara K; Koyama Y; Hanaki T; Miyatani K; Matsunaga T; Yamamoto M; Morizane S; Tokuyasu N; Sakamoto T; Fujiwara Y
    Surg Case Rep; 2022 Oct; 8(1):191. PubMed ID: 36205818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surgical, survival and quality of life outcomes in over 1000 pelvic exenterations: lessons learned from a large Australian case series.
    Steffens D; Solomon MJ; Lee P; Austin K; Koh C; Byrne C; Karunaratne S; Hatcher S; Taylor K; McBride K
    ANZ J Surg; 2023 May; 93(5):1232-1241. PubMed ID: 36869215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes following repeat exenteration for locally advanced pelvic malignancy.
    Blake J; Koh CE; Steffens D; De Robles MS; Brown K; Lee P; Austin K; Solomon MJ
    Colorectal Dis; 2021 Mar; 23(3):646-652. PubMed ID: 33058495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.